Marimed (MRMD) CFO Mario Pinho Exercises RSUs, 88,276 Shares
$MRMD · MARIMED INC.Research Summary
AI-generated summary of this SEC filing
Marimed (MRMD) CFO Mario Pinho Exercises RSUs, 88,276 Shares
What Happened
Mario Pinho, Chief Financial Officer of Marimed, reported the conversion/exercise of equity awards on July 15, 2026. The filing shows 88,276 shares acquired in a conversion/exercise (code M). The report also records dispositions of 49,995 and 38,281 shares (both at $0) related to derivative conversions, and 30,589 shares were withheld by the issuer to satisfy tax withholding obligations (code F) with a reported withholding value of $2,025.
Key Details
- Transaction date: July 15, 2026; Form 4 filed July 17, 2026 (appears timely).
- Reported entries:
- Exercise/conversion (M): 88,276 shares acquired @ $0.00 (no cash paid).
- Payment of tax liability (F): 30,589 shares disposed @ $0.07 = $2,025 (shares withheld to cover taxes).
- Exercise/conversion (M): 49,995 shares disposed @ $0.00 (reported as disposition).
- Exercise/conversion (M): 38,281 shares disposed @ $0.00 (reported as disposition).
- Footnotes from the filing:
- RSUs convert 1-for-1 into common stock (F1).
- Shares withheld by the issuer were used to satisfy tax withholding on vesting (F2).
- Some RSU grants referenced have remaining future vesting/installment dates (grants from July 15, 2024 and April 15, 2026 with remaining vesting dates listed in F3 and F4).
- Shares owned after the transactions: not included in the provided excerpt of the filing.
Context
These entries reflect the vesting/conversion and settlement of restricted stock units/options rather than open-market buys or discretionary sales. The withholding of shares to cover taxes is common in RSU vesting events and is the only transaction with a cash value reported (~$2,025). The filing does not provide an explanation of the zero-dollar dispositions beyond the transaction codes; they appear related to the mechanics of conversion/settlement of award instruments.